Many patients with epilepsy caused by hypothalamic hamartomas (HHs) have cognitive impairments during the course of the disease or following neurosurgical treatment. The purpose of this study was to assess cognitive function in these patients, as well as factors influencing preoperative cognitive performance and cognitive outcome after neurosurgical treatment. Using the two largest and most detailed neuropsychology datasets on HH and epilepsy from two centers, we retrospectively report on cognitive functions in 48 patients with structural epilepsy due to HH (mean age AE standard deviation [SD] 20 AE 12 years, range 5-53 years, median 16 years; disease duration mean 17 AE 11 years). Intelligence, verbal learning and recall, and speed and executive functions (processing speed and cognitive flexibility) were assessed before and on average 19 (AE11) months after surgery (interstitial radiosurgery: N = 22; neurosurgical resection/disconnection: N = 26). Prior to neurosurgical treatment, 52% of patients showed impaired executive and 62% showed reduced verbal memory functions. A trend for a detrimental effect of higher drug load on cognitive functioning was found. After neurosurgical treatment, intellectual functions for the entire cohort tended to increase. This correlated with improved seizure frequency and decreased number of antiepileptic drugs (AEDs). However, postoperative outcomes for individual patients were highly variable, with significant deteriorations in 17% (processing speed) to 34% (cognitive flexibility and verbal learning), and performance increases in 17% (intellectual functioning) up to 39% (processing speed) of the patients. Higher levels of presurgical performance were significant predictors of cognitive decline after surgery. These results are highly relevant for patient consultation and may help with therapeutic decisions. KEY WORDS: Neuropsychology, Memory, Iodine seed, Transcallosal resection, Endoscopic resection, Stereotactic radiosurgery.
Cognitive abilities and behavior are often impaired in patients with epilepsy due to hypothalamic hamartomas (HHs), but influencing factors have not been adequately understood. [1] [2] [3] [4] [5] [6] [7] [8] [9] Likelihood for more severe cognitive impairment is predicted by the following: (1) earlier age of first seizure onset, 3 (2) higher seizure frequency, 8 (3) larger HH lesion size, 7 and (4) higher number of antiepileptic drugs (AEDs) at the time of testing. 7 Furthermore, because pharmacotherapy is poorly effective in these patients, neurosurgical approaches have become an option to effectively treat their seizures. functioning, epilepsy due to HH as well as its surgical treatment carries with it the risk of further postoperative cognitive disturbances. In particular, structures of the hippocampal-thalamic pathways, for example, the mammillary bodies or columns of fornix, are adjacent to the lesion and known to be important for memory functions. [20] [21] [22] Several different neurosurgical approaches have been successfully established to overcome highly drug-resistant epileptic seizures in these patients: transcallosal, anterior interforniceal, or pterional approaches for surgical resection 11, 12, 23, 24 ; transcortical and transventricular endoscopic approaches for disconnection or resection 13, 14 ; radiosurgery and brachytherapy [15] [16] [17] [18] 25 ; and thulium laser for coagulation 14 and stimulation of the mamillothalamic tract. 19 The purpose of this study was to illuminate clinical factors influencing cognitive functions, especially regarding verbal memory and executive functions, in one of the largest cohort to date of patients with epilepsy due to HH prior to any neurosurgical treatment. Furthermore, we analyzed cognitive outcome after neurosurgical intervention. These results are of relevance for the counseling of patients with the rare syndrome of epilepsy due to HH.
Patients and Methods

Patients
Patients treated either at Freiburg University Medical Center (FUMC), Germany or at Barrow Neurological Institute at St. Joseph's Hospital and Medical Center at Phoenix, Arizona, U.S.A. (Barrow) were retrospectively analyzed. Figure 1 illustrates the flow of cases.
At FUMC, 37 consecutive patients (13 female, age mean AE standard deviation [SD] 23.7 AE 13.0 years, range 3-53 years) with drug-resistant epilepsy due to HH were assessed and then treated using 125 I-seed implants into the target volume of the hypothalamic hamartoma between 1999 and 2012. A subgroup of 28 patients were able to undergo standardized neuropsychological assessment; the remaining 9 patients could not perform standardized psychometric testing due to a lack of cooperation caused by a behavioral disorder and/or mental retardation. Furthermore, four additional patients needed to be excluded, as three of them received prior neurosurgical treatment (partial resection, Gamma knife, and LINAC), and in one case, two neurosurgical methods (seed and LINAC) were applied before follow-up assessment. Moreover, two patients had to be excluded because of missing data. We report on the remaining 22 patients who received brachytherapy. In part (15/22 patients, 68.2% overlap), this patient sample was reported on in previous publications on overall outcome 18 as well as cognitive outcome 6, 25 of interstitial radiosurgery in patients with epilepsy due to HH. Fifty-two consecutively referred patients (20 female, age mean + SD 14.3 AE 9.6 years, range 3-55 years) who 
Key Points
• Patients with HH show reduced preoperative cognitive functions as compared to age-matched normative sample • Higher AED load tends to have detrimental effects on cognition prior to any neurosurgical treatment • After neurosurgery (interstitial radiosurgery or transcallosal/endoscopic resection) a trend for increased intellectual functioning was seen • Higher levels of presurgical cognitive performance increased likelihood of detectable postsurgical cognitive decline • Findings highlight benefits of surgical intervention for patients who already demonstrate significant intellectual/cognitive impairment underwent surgical resection or hamartoma disconnection 26, 27 at Barrow between 2003 and 2007 were considered for study participation. One patient was excluded because he was seen for postsurgical neuropsychological evaluation only. An additional eight patients were excluded because they were essentially untestable at the time of their presurgical evaluation due to the severity of their intellectual disability and/or behavioral difficulties. One additional patient was excluded because he underwent Gamma Knife after his resection, but before neuropsychological follow-up. Thus 42 eligible patients were invited to return for postsurgical neuropsychological evaluation or provide results from a comparable evaluation, if available. Ten (24%) of the patients invited for participation were lost to follow-up or were unable to travel to Barrow for postsurgical evaluation, leaving 32 patients who underwent surgical resection included in this study. A further six patients were excluded due to either missing psychometric data (N = 5) or treatment combination of two neurosurgical methods between baseline and follow-up assessment (endoscopic plus transcallosal interforniceal resection in one patient). For the Barrow patients meeting inclusion criteria, there were no significant differences between participants and nonparticipants when evaluated for age, sex, duration of epilepsy, number of AEDs at time of surgery, seizure frequency or type, HH lesion type or size, history of mental retardation, surgical approach, extent of resection, surgical complications (thalamic infarction), or seizure outcome. The entire Barrow patient sample from SJHMC was described in a previous publication. 24 For clinical details of the complete patient group (N = 48) see Table 1 .
The study was approved by the institutional review board for human research at St. Joseph's Hospital and Medical Center, Phoenix, U.S.A., and the ethics committee of the University Freiburg and participants gave their informed written consent.
Neuropsychological evaluation
Cognitive performance was evaluated prior to and a mean of 19 AE 11 (range 3-46) months after neurosurgical treatment using standardized psychometric tests: verbal learning and verbal delayed free recall was assessed using a word list learning test. Except for the young patients, most patients included in the current sample were assessed using the English or German version of the Rey Auditory Verbal learning test (RAVLT). 28 Three young American patients were investigated using the California Verbal Learning TestChildren's Version (CVLT-C) 29 instead of the RAVLT. Altogether preoperative and postoperative data of verbal memory performance were available in 38 patients (mean age 23.7 AE 13.0). For assessment of verbal memory, parallel versions were applied across the two time-points, except for the CVLT-C, for which only one version is available.
Furthermore, speed and executive functions were measured using the Trail Making Test (Part A: processing speed; Part B: cognitive flexibility), using either the adult or the children's intermediate version. 30 Test raw scores were transformed into standardized zscores according to the age-matched normative data of the individual psychometric tests. To assess cognitive changes after treatment, difference scores between presurgical and postsurgical assessment were computed.
To describe general intelligence of the patient population, the age-and language-appropriate long or short version of the Wechsler Intelligence Scale, [31] [32] [33] [34] or in three German patients, a multiple-choice vocabulary test 35 similar to the National adult Reading Test was used. Based on these intelligence quotient (IQ) scores or IQ estimates, 7, 36 intelligence categories were defined as follows according to the normative mean (100) and standard deviation (SD 15) of intelligence quotients: >2 SD below the mean (IQ <70), between 1 and 2 SD below the mean (IQ between 70 and 85), average (IQ 85-115), and >1 SD above the mean (IQ >115).
Seizure frequency and severity
Prior to surgery and at follow-up, seizure types (gelastic seizures only or multiple seizure types) as well as the frequency were assessed according to the available medical records. Frequency was categorized as follows: (1) one or more seizures per day, (2) less than one seizure per day, or (3) no seizures.
Statistical analyses
Because some variables were not normally distributed and revealed outliers, nonparametric analyses were applied: To evaluate influencing factors on cognitive functions prior to any treatment, rank correlations (Kendall Tau-b, onesided) were analyzed between z-scores of psychometric measures (presurgical intelligence, verbal learning, verbal delayed free recall, processing speed, and cognitive flexibility) and the factors age, disease duration, presurgical hamartoma volume and type, number of AEDs (AED load), and seizure frequency.
To evaluate preoperative to postoperative changes in zscores of cognitive performance, Wilcoxon signed-rank tests were applied. Furthermore, frequencies of postoperative cognitive changes (between presurgical and postsurgical z-scores) of ≥1 SD were reported.
In addition, rank correlations (Kendall Tau-b, one-sided) were computed to estimate the influence of the variables age, disease duration, presurgical cognitive performance, hamartoma type and volume, type of treatment, follow-up interval, and seizure frequency as well as number of AEDs taken after surgery on cognitive outcome parameters (changes in z-scores between presurgical and postsurgical assessment of intelligence, verbal learning, verbal delayed free recall, processing speed, and cognitive flexibility). Chisquare test was applied to evaluate differences in seizure frequency after surgery between treatment approaches (interstitial radiosurgery vs. resection). We applied Bonferroni corrections to the analyses due to multiple comparisons.
Results
Preoperative cognitive functions
Seventeen patients of the complete patient cohort (19.1%) could not undergo standardized psychometric assessment due to a lack of cooperation caused by behavioral disorder and/or mental retardation.
Prior to neurosurgical treatment testable patients presented a mean IQ of 87.0 (SD 20.6): 15 patients (31%) presented intellectual functioning >2 SD below the normative mean, 9 patients (19%) between 1 and 2 SD below the normative mean, and 23 patients (48%) average intelligence (within 1 SD of the mean). Only one patient (2%) presented with an IQ >1 SD above the mean. Cognitive functions were below the normative mean in 50% (intelligence and processing speed) to 62% (verbal delayed recall) of the patients prior to surgery (Fig. 2) .
For detailed neuropsychological standardized test scores before surgery see Table 2 ; test raw scores are additionally supplied in Table S1 . Eighty-five percent of the patients presented with one seizure or more a day; most patients (90%) had multiple seizure types (Table 1) .
After correction for multiple comparisons, none of the evaluated correlating factors survived the statistical threshold (Bonferroni corrected p = 0.0017). However, presurgical cognitive flexibility performance showed a trend to be negatively influenced by a higher number of AEDs taken (p = 0.004, Table 2 ).
Postoperative cognitive changes across all patients
Twenty-two patients were treated with interstitial radiosurgery by implantation of 125 I-seeds (two patients received two seeds between the presurgical and postsurgical assessments). In 18 patients, the HH was resected or disconnected by endoscopic surgery, and 8 patients received transcallosal interforniceal resection of their hamartoma.
In some patients receiving resective surgery (N = 5, 19%), surgical complications occurred in the form of a thalamic infarction. Although most patients who sustained a thalamic infarction were clinically asymptomatic, they showed less increase in intellectual functioning and cognitive flexibility performance after surgery (p = 0.033 and p = 0.044, respectively). In patients treated with interstitial radiosurgery, in the postoperative course, seven of these patients (32%) showed transient brain edema extending from the hamartoma to adjacent brain regions on magnetic resonance imaging (MRI). Occurrence of edema was not correlated with cognitive outcome. Furthermore, one patient revealed a small asymptomatic left frontal bleed along the implantation trajectory that had regressed at follow-up.
Nonparametric comparison of cognitive performance prior to and after surgery showed a trend for a performance increase in IQ (p = 0.017, Bonferroni corrected pthreshold = 0.01). For an overview of changes in cognitive performance after neurosurgical treatment see Table 3 and Figure 3 .
Frequencies of significant individual cognitive domain changes in z-scores (>1 SD) were as follows: intellectual functioning improved >1 SD in 16.7% of the patients (83.3% unchanged, no patient deteriorated), verbal learning performance decreased >1 SD in 34.2%, and improved in 18.4% of the patients (remained unchanged in 47.4%), verbal delayed recall deteriorated in 25.0% and improved in 22.2% of the patients (52.8% were stable). Processing speed decreased in 17.1%, and improved in 39.0% of the patients (43.9% remained unchanged), cognitive flexibility performance declined in 34.2%, and increased in 28.9% of the patients (36.8% were stable). For an overview see Figure 3 .
After Bonferroni correction (corrected pthreshold = 0.001), better presurgical performance was significantly associated with presurgical to postsurgical declines (of z-scores) in verbal learning (p = 0.001) and processing speed (p = 0.001). The other potential influencing factors were not significantly associated with cognitive outcome after correction for multiple comparisons. For detailed presurgical and postsurgical psychometric scores see Table 3 and Figure 3 .
After neurosurgical treatment, patients showed significant reduction in seizure frequency (p < 0.001): After surgery, 29.2% of the patients were completely seizure free and 31.3% had fewer than one seizure per day, but 29.2% still experienced at least one seizure every day. In addition, the number of AEDs taken was lower at follow-up Postoperative changes with respect to neurosurgical treatment Prior to surgery, the German and the American patient samples did not differ concerning their cognitive performance (p > 0.2), but revealed statistically significant demographic and clinical differences (see below and Table 1 ). Patients receiving resective surgery turned out to be younger (p < 0.001) with younger age at disease onset (p < 0.001) and shorter disease durations (p = 0.005). Furthermore, they had longer follow-up intervals (p < 0.001) and differed in hamartoma type. According to the Delalande classification, most patients undergoing resection had HH type II, with relatively few having types III or IV. Thus, head-to-head comparison of the two surgical approaches is not highly informative as the surgical treatment groups are composed of different patients. For the sake of completeness, we report results of group comparisons bearing in mind the known limitations.
After surgery, a significantly higher number of patients were seizure free after resection (transcallosal or endoscopic) than after interstitial radiosurgery (p < 0.001). Likewise, patients after resective surgery had to take fewer AEDs than patients after radiosurgery (p = 0.008). A difference in cognitive outcome between types of surgery was only seen regarding change of cognitive flexibility performance (Bonferroni corrected p-threshold = 0.01): patients treated with a resective approach were more likely to 
Discussion
In our cohort, patients with epilepsy due to HH showed reduced cognitive functions, especially executive (52% of patients impaired) and verbal memory performance (62% of patients impaired). Cognitive abilities as well as behavior have been described as deteriorated in these patients. [1] [2] [3] [4] [5] [6] [7] [8] The numbers of patients in our study included only testable patients. Inclusion of patients who could not undergo standardized psychometric assessments due to behavioral disorder and/or mental retardation (19.1% of the complete cohort) would have further increased these numbers.
Due to the anatomic proximity of the hypothalamus to memory-related structures, memory functions seem particularly at-risk during the course of the disease or treatment. 10 Furthermore, the hypothalamus is connected to several prefrontal neocortical regions. 37 These widespread connections to cognitively important brain areas might thereby be relevant for cognitive deterioration in these patients.
Most of the patients in our sample were on multiple AEDs. In our sample, cognitive functions tended to be negatively influenced by a higher number of AEDs taken, which is supported by the literature 7 : Each additional AED prescribed resulted in lower performance, especially in executive functions including the Trail Making Test used in our study. 38 In addition, correlation between the level of intellectual functioning and the number of AEDs was reported. 7 Other factors reported in the literature, such as higher seizure frequency 8 and larger HH lesion size, 7 did not show significant influence on cognitive performance in our patient sample. This might be because different psychometric measures were used. Our patient cohort consisted of a large number of patients and thus was heterogenous concerning factors such as age and age at seizure onset as well as at assessment, and also regarding disease severity. Furthermore, in our retrospective data collection, seizure frequency was only available in categories (≥1 seizure per day, <1 seizure per day, or no seizures) that could have influenced the results. On the other hand, our findings support the conclusion of other studies that cognitive performance is not influenced only by seizure activity. 2 Regarding HH size, a strong relationship between larger lesion size and lower cognitive performance in patients with very early seizure onset (first month of life) was reported. 2 In our patient sample, age at disease onset ranged from 0 to 12 years, which might have influenced the results. Analyses of age subgroups may further enlighten this subject, but substantially reduce statistical power. Furthermore, type or rather location of the HH was shown to correlate with cognitive performance. 7 Intrahypothalamic large hamartomas are more commonly associated with cognitive deterioration.
Postsurgical cognitive outcome is of strong relevance for patients undergoing neurosurgical treatment of epilepsy due to hamartoma in the hypothalamus. Therefore, standardized assessment of treatment-emergent cognitive risks and benefits is highly relevant for therapeutic decisions and patient consultation on timing and choice of treatment. In our retrospective analysis, utilizing stringent statistical methods (nonparametric analysis with Bonferroni correction), we found a trend of improvement in intellectual functioning across all subjects. These findings are in line with those of previous reports about postoperative cognitive changes, 24, 39 and may be a result of postsurgical lower frequency or less severity of seizures, which has been shown to be relevant for postoperative cognitive improvements. 40, 41 In addition, a lower postoperative drug load, improved behavior, as well as practice effects may also have contributed to these changes.
Higher baseline cognitive functioning was associated with increased risk of postoperative cognitive decline. Assessment of therapeutic effects needs to take into consideration the cognitive performance level at baseline. Higher adequacy of presurgical cognitive functions associated with the structures placed at risk through surgery has been shown to be a predictor of greater cognitive decline after neurosurgical treatment, 42 and this was seen in our sample. However, it should also be acknowledged that higher levels of cognitive functioning at baseline facilitate the psychometric detection of subsequent cognitive decline; which is difficult to detect when individuals are already significantly impaired, as were many of the individuals in our sample. It is also important to note that the syndrome of HH with epilepsy is frequently associated with cognitive deterioration over time. 9, 43 Thus, the risks of treatment-associated cognitive decline in patients with relatively intact cognitive skills must be weighed against the risks of future cognitive decline without treatment.
To compare different neurosurgical treatment options for HH-induced epileptic seizures, it would be desirable to undertake a randomized controlled trial with pretreatment and posttreatment assessment of cognition and seizures. Furthermore, the influence of age (at disease onset as well as at time of neurosurgical treatment) and follow-up interval on cognitive development in different age groups would be important to evaluate in a large cohort of patients. In our sample, age-associated parameters (age at disease onset, age and disease duration at time of surgery) were not significantly correlated with cognitive performance.
So far, postoperative cognitive outcome seems to be influenced by longer disease duration, 18 age at surgery, 24 HH type, 24 and presurgical performance level. 24, 25 The large number of potential influencing variables limited statistical power, even though this is one of the largest datasets on cognitive data in patients with HH to date. Furthermore, the results may have been affected by combining different versions of tests into normed data in order to increase statistical power.
There are some limitations to this study, and further considerations are needed: The assessment of patients with HH is usually limited in that a considerable subgroup of patients cannot perform standardized cognitive assessment due to significant mental and/or behavioral impairment. Therefore, analyses of factors predicting postoperative changes in these patients are scarce, but needed.
Moreover, in our sample we were confronted with the problem of missing data resulting from retrospective data collection, and therefore provided an additional table (Table S2) comprising clinical information about missing data related to age, age at onset and duration, disease severity as measured by hamartoma volume and type, as well as seizure frequency and the treatment type. This table shows that patients with missing data points are on average younger, and have an earlier age at epilepsy onset and shorter disease duration. This underscores the difficulties in the assessment of young patients in general and in children with a syndrome associated with frequent behavioral disturbances, in particular. 43, 44 To overcome this limitation, future studies may assess skills of everyday life as well as quality of life metrics before and after surgery. This might overcome the problem of missing data in young patients and those with behavioral disorders and/or mental retardation. It may also add valuable information on patients with average performance on standardized psychometric tests, but who have difficulties coping with the demands of day to day life.
Often limitations in daily living skills in patients with HH are not caused solely by cognitive impairments, but in fact to a large extent by behavioral difficulties. Improvements in behavior (e.g., better frustration tolerance, and less aggression or hyperactivity) after neurosurgical treatment have been described in the literature 44, 45 and were also observed in our patient sample. Thus postoperative improved endurance during neuropsychological assessment likely facilitated improved results on psychometric cognitive measures. Therefore, the assessment of cognitive performance in patients with HH should be accompanied by standardized behavioral assessments, especially assessment of coping skills. The potential role of central precocious puberty in influencing behavioral disturbances should also be given further consideration.
Both cognitive decline and behavioral deterioration prior to any neurosurgical treatment have been reported in the past 2, 3, 5, 7, 8, 43, 44, 46 and were also found in our patient sample. Prior impairments of memory functions might have led to a floor effect and therefore no further significant decline was seen.
Conclusion
Patients with epilepsy due to HH demonstrated cognitive impairment, particularly in the domains of verbal memory and executive functions. Our results indicate detrimental effects of higher drug load on cognitive functioning prior to any neurosurgical treatment. As a trend, there is evidence for increased postsurgical performance in intellectual functioning. Higher level of presurgical baseline performance was a predictor of postsurgical decline in some cognitive functions. Findings highlight the benefits of surgical intervention for patients who already demonstrate significant intellectual/ cognitive impairment. These results might help clinicians regarding patient counseling during the course of the disease or prior to neurosurgical treatment.
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